Large-scale testing (Phase 3)Ended earlyNCT03783923
What this trial is testing
Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)
Who this might be right for
Limb-Girdle Muscular Dystrophy
PTC Therapeutics 11
Showing 13 of 13 results